MedPath

Fully Covered Self-expandable Metal Stents (FCMS) in Benign Biliary Strictures

Not Applicable
Completed
Conditions
Biliary Stricture
Interventions
Device: Placement of a FCMS in the biliary tract of the patients
Registration Number
NCT02105181
Lead Sponsor
Société Française d'Endoscopie Digestive
Brief Summary

Endoscopic treatment of benign biliary strictures can be challenging. Balloon dilation and/or plastic stent placement are currently the most popular techniques. Partially covered self-expandable metallic stents have also shown to be effective but can be difficult to remove. A novel fully covered metallic stent has recently been developed.

The aim of this study was to prospectively evaluate the placement of fully covered self-expandable metallic stents (FCSEMS) in this setting.

Detailed Description

After inclusion, an endoscopic procedure (ERCP) was performed in all patients in order to place a FCMS across the benign biliary stricture. The FCMS was left in place for 6 months and then extracted during a second ERCP procedure. An opacification was performed to assess the efficacy of stenting. Patients were followed up during one year after FCMS extraction.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • a history of liver transplantation, chronic pancreatitis or biliary surgery
  • impairment of liver function tests such as elevated liver enzymes and/or cholestasis
  • a biliary stricture associated with ductal dilation detected by US, CT or MRI, with a minimum distance of 2cm between the upper stricture's edge and the lower limit of the main biliary confluence or liver hilum .
Exclusion Criteria
  • an uncertainty about the benign nature of the stricture
  • an intra-hepatic cholangitis and/ or a stricture extending beyond the hilum

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fully covered metal stent (FCMS)Placement of a FCMS in the biliary tract of the patientsThere is one arm in the study : the intervention consists on placing a device which is a fully covered metal stent in the biliary tract of all patients
Primary Outcome Measures
NameTimeMethod
Initial success rate of temporary FCMS placement6 months

Absence of biliary stricture or as an attenuated stricture on cholangiogram after removal of FCMS

Secondary Outcome Measures
NameTimeMethod
Final success18 months

Absence of biliary stricture or the presence of an attenuated stricture and normal liver function tests at the end of follow up.

Stricture recurrence18 months

Both clinically and ERCP-documented recurrence of stricture after an initial success.

Trial Locations

Locations (1)

Hôpital Cochin

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath